MediciNova, Inc. (MNOV) Social Stream



MediciNova, Inc. (MNOV): $2.27

0.02 (+0.89%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MNOV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 455

in industry

Medicinova Inc (MNOV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MNOV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 3 $27 $10 $16.5 $2.21 646.61%
2021-11-30 3 $27 $10 $16 $2.21 623.98%

The Trend in the Analyst Price Target


Over the past 46 weeks, MNOV's average price target has gone down $2.5.

MNOV reports an average of 305.82% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 2 28.0 11 18.00 3.65 393.15%
2021-05-22 0 26.5 11 17.50 4.12 324.76%
2021-03-20 1 26.5 11 17.63 5.81 203.44%
2021-02-06 2 26.5 11 18.50 6.57 181.58%
2021-08-01 0 28.0 11 18.00 3.63 395.87%

MNOV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 31 days, MNOV's average broker recommendation rating improved by 0.67.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MNOV as an investment opportunity.

  • In terms of how Medicinova Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 195.59% of that group.
  • Medicinova Inc's variance in analysts' estimates is lower than -89.43% of all US stocks.
  • Medicinova Inc's number of analysts covering the stock is greater than 27.78% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, Medicinova Inc's average analyst price target is greater than 54.72% of them.

In the Pharmaceutical Products industry, MIST, MIRM, and MGTA are the three stocks most similar to Medicinova Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for MNOV? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8046 seconds.